RenovoRx encountering "a lot of enthusiasm" for innovative cancer platform

By: TheNewswire.com

June 29, 2023 at 11:42 AM EDT

RenovoRx Inc (NASDAQ: RNXT) CEO Shaun Bagai speaks to Thomas Warner during a visit to Europe to present at the ESMO World Congress on Gastrointestinal Cancer (ESMO GI) in Barcelona. Bagai gives an overview of the lead candidate product RenovoGem that he has presented to the Congress, before going on to explain where the product is in its development cycle. He says the product has met with "a lot of enthusiasm" so far and reveals his hopes of getting early approval from the FDA "next year or early in 2025."

Contact Details

Proactive United States

Proactive United States

+1 347-449-0879

action@proactiveinvestors.com

More News

D-Wave: Time to Buy the Dip? Or is the Fall Just Starting? ↗

Today 18:55 EST

Via MarketBeat

Hims, Block, and NRG Just Launched Huge Stock Buybacks ↗

Today 17:32 EST

Via MarketBeat

Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3 ↗

Today 16:45 EST

Via MarketBeat

JPMorgan and Goldman Upgrade MP Materials Amid Defense-Driven Demand Outlook ↗

Today 16:15 EST

Via MarketBeat

Why Circle Stock Is Falling—and Why Some Analysts See Big Upside ↗

Today 15:33 EST

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	226.28	+5.59 (2.53%)
AAPL	275.92	+4.43 (1.63%)
AMD	215.05	+11.27 (5.53%)
BAC	51.93	+0.37 (0.72%)
GOOG	318.47	+18.82 (6.28%)
META	613.05	+18.80 (3.16%)
MSFT	474.00	+1.88 (0.40%)
NVDA	182.55	+3.67 (2.05%)
ORCL	200.28	+1.52 (0.76%)
TSLA	417.78	+26.69 (6.82%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.